Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tim Babinchak"'
Autor:
Hugo Astacio, Deborah M. Anderson, Jason S. Richardson, Harpreet Sahota, Christine Hall, Tim Babinchak, Geraldine S Parrera
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 70(9)
Background Botulism is a rare, life-threatening paralytic illness. Botulism Antitoxin Heptavalent (A,B,C,D,E,F,G)-(Equine) (BAT) manufactured by Emergent BioSolutions Canada Inc is an equine-derived heptavalent botulinum antitoxin product indicated f
Aims: Real-world evidence on the safety profile and costs associated with immune thrombocytopenic purpura (ITP) treatment in adults is lacking. This study quantifies and compares adverse event (AE) crude rates and costs associated with ITP treatments
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a13d9d4ff20504564cac76c2e5edbf2f
Autor:
Krasimir, Vasilev, Galina, Reshedko, Remus, Orasan, Miguel, Sanchez, Juri, Teras, Tim, Babinchak, Gary, Dukart, Angel, Cooper, Nathalie, Dartois, Hassan, Gandjini, Russ, Orrico, Evelyn, Ellis-Grosse, Silvestrs, Zebolds
Publikováno v:
Journal of Antimicrobial Chemotherapy. 62:i29-i40
Objectives To evaluate the efficacy and safety of tigecycline in patients with selected serious infections caused by resistant Gram-negative bacteria, or failures who had received prior antimicrobial therapy or were unable to tolerate other appropria
Publikováno v:
Diagnostic microbiology and infectious disease. 79(2)
Given increasing resistance, therapeutic options to treat MRSA soft tissue infections should be evaluated. This pooled analysis evaluated data from subjects enrolled in 6 tigecycline clinical trials with documented MRSA complicated skin and skin stru
Autor:
Robert E. Badal, Tim Babinchak, Samuel K. Bouchillon, Meredith Hackel, Stephen Hawser, Sibylle H. Lob, Daryl J. Hoban
Publikováno v:
Diagnostic microbiology and infectious disease. 76(3)
This report summarizes data from the Study for Monitoring Antimicrobial Resistance Trends 2005-2010 to identify trends in susceptibility from intra-abdominal infections in North America. Escherichia coli and Klebsiella pneumoniae were the most freque
Autor:
Heidi Leister-Tebbe, Ronald Pedersen, Brian Warren, Tim Babinchak, Niels Qvist, Edward T Zito, Paul C. McGovern
Publikováno v:
Qvist, N, Warren, B, Leister-Tebbe, H, Zito, E T, Pedersen, R, McGovern, P C & Babinchak, T 2012, ' Efficacy of tigecycline versus ceftriaxone plus metronidazole for the treatment of complicated intra-abdominal infections : results from a randomized, controlled trial ', Surgical Infections, vol. 13, no. 2, pp. 102-9 . https://doi.org/10.1089/sur.2011.048
This randomized, open-label, multi-center trial compared tigecycline (TGC), a broad-spectrum glycylcycline, with ceftriaxone-metronidazole (CTX/MET) for the treatment of complicated intra-abdominal infections (cIAI).Eligible subjects were randomized
Publikováno v:
International journal of antimicrobial agents. 37(3)
During 2004-2009, 20004 isolates of Staphylococcus aureus were collected from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.). Of these isolates, 8249 (41.2%) were meticillin-resistant S. aureus (MRSA) and 11755 (58.8%) were meticillin-s
Publikováno v:
The Journal of Trauma: Injury, Infection, and Critical Care. 45:1111